Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,293 public trials 504 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

LDE225 and Paclitaxel in Solid Tumors

NCT01954355

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Istituto Oncologico della Svizzera Italiana Bellinzona, Switzerland
  • Kantonsspital Graubünden Chur, Switzerland
  • Centre Pluridisciplinaire d'Oncologie CHUV Lausanne, Switzerland
  • Kantonsspital St. Gallen Sankt Gallen, Switzerland
View Trial Details
Completed

Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer

NCT00628251

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Boca Raton, Florida, United States
  • Research Site Boston, Massachusetts, United States
View all 24 locations
View Trial Details
Completed

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

NCT01770353

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +35 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • HonorHealth Scottsdale, Arizona, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer

NCT02751918

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Oklahoma University Health Science Center Oklahoma City, Oklahoma, United States
  • UZ Leuven Gasthuisberg Leuven, Belgium
View Trial Details
Completed

A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer.

NCT03681548

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • MNJ Institute of Oncology & Regional Cancer Center Hyderabad, Andhra Pradesh, India
  • HCG City Cancer Centre Vijayawada, Andhra Pradesh, India
  • Mahatma Gandhi Cancer Hospital & Research Institute Visakhapatnam, Andhra Pradesh, India
  • Nirmal Hospital Pvt. Ltd. Surat, Gujarat, India
View all 15 locations
View Trial Details
Completed

Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer

NCT01735071

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Azienda Ospedaliera Spedali Civili di Brescia Brescia, Italy
  • Istituto Europeo di Oncologia Milan, Italy
  • AO Fatebenefratelli e Oftalmico Milan, Italy
  • Azienda Ospedaliera S. Gerardo Monza, Italy
View Trial Details
Completed

Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer

NCT00445887

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California San Diego San Diego, California, United States
View all 66 locations
View Trial Details

Related conditions